 Forbes | 2nd-Gen Stents Square Off MedPage Today The investigational Resolute zotarolimus-eluting stent proved noninferior to the everolimus-eluting Xience regarding target vessel failure. The overall rate of definite/probable stent thrombosis was low among the two groups, with no statistical ... TWENTE Published: New Medtronic Resolute Heart Stent Matches Abbott's Xience |
